alexa Interview | Hosam ElbaznbspPharmaceutica Analytica Acta
ISSN : 2153-2435

Pharmaceutica Analytica Acta
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..
Hosam Elbaz
Hosam Elbaz

Hosam Elbaz
Department of Basic Pharmaceutical Sciences
West Virginia University
Tel: 304-376-3430
Read Interview session with Hosam Elbaz


Dr. Hosam A. Elbaz has received his PhD in West Virginia University during the period of 2007 to 2011. Currently, he is working as a postdoctoral fellow Wayne State University School of Medicine. He is serving as an editorial member of Journal of Bioengineering and Biomedical Sciences and Journal of Nanomedicine and Nanotechnology. He is a member of American Society of Pharmacology and Experimental Therapeutics ASPET, American Association of Pharmaceutical Scientists AAPS, American Chemical Society ACS, Egyptian General Syndicate of Pharmacists, and Golden Key International Honor Society.

Research Interest

The first aspect of my research interest is different pharmaceutical aspects of cancer therapeutics. Such aspects encompass discovery of novel anticancer agents, elucidation of their mechanism of action, and pre-clinical development. The second aspect of my research interest is employing nano-medicine and nanotechnology in cancer therapeutics through developing different types of nano-particles for targeted drug deliver, therapeutic gene delivery and other potential therapeutic applications in cancer therapeutics.


1. How many years have you been associated with the current research?
7 years.

2. What is the research topic you are working on now?
Inflammation driven carcinogenesis.

3. What are attributes for a quality article?
A top quality article should discuss novel, yet significant topic without undermining the research integrity in any perspective.

4. Do you have any research funding (NIH or other national funding) now?
Not yet.

5. When did you become an editor of OMICS Journal?
I believe that was around April 2012.

6. Where can the journal find the maximum scope in terms of niche?
I’d say it is still too early to effectively answer that question at the time being.

7. What is your greatest career accomplishment?
Acquiring my PhD in Pharmaceutical and Pharmacological Sciences in 4 years and 5 months, while the average graduate needs 6 years for a similar degree.

8. How does the published scientific content assist the potential researchers?
By providing novel findings that advance the field and help potential researchers in tackling future problems.

9. What is the purpose of serving as an editor?
Contributing to scientific development in my field.

10. Do you have any patents?
I have 1 provisional patent application.

11. Have you contributed any editorials or papers (any types) to OMICS Journals in the past two years?
Not yet.

12. Do you plan to contribute any editorials or papers to OMICS Journals in the next year?
Possibly yes.

13. How would you define your experience with OMICS Group?
I’d say it is still too early to effectively answer that question at the time being.

14. Your opinion on conducting Editorial Board meetings at related Conferences?
That should be done.

15. Would you recommend OMICS to your friends or colleagues?
That would depend on how rigorous the peer review process adopted by the journal performs.

16. How do you differentiate Pharmaceutica Analytica Acta with other journals in the field?
I’d say it is still too early to effectively answer that question at the time being.

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version